These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16076536

  • 1. Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells.
    Managit C, Kawakami S, Yamashita F, Hashida M.
    Int J Pharm; 2005 Sep 14; 301(1-2):255-61. PubMed ID: 16076536
    [Abstract] [Full Text] [Related]

  • 2. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C, Kawakami S, Yamashita F, Hashida M.
    J Pharm Sci; 2005 Oct 14; 94(10):2266-75. PubMed ID: 16136555
    [Abstract] [Full Text] [Related]

  • 3. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S, Yamashita F, Nishikawa M, Takakura Y, Hashida M.
    Biochem Biophys Res Commun; 1998 Nov 09; 252(1):78-83. PubMed ID: 9813149
    [Abstract] [Full Text] [Related]

  • 4. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
    Ishida E, Managit C, Kawakami S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2004 Jun 09; 21(6):932-9. PubMed ID: 15212156
    [Abstract] [Full Text] [Related]

  • 5. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.
    Murao A, Nishikawa M, Managit C, Wong J, Kawakami S, Yamashita F, Hashida M.
    Pharm Res; 2002 Dec 09; 19(12):1808-14. PubMed ID: 12523658
    [Abstract] [Full Text] [Related]

  • 6. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
    Shigeta K, Kawakami S, Higuchi Y, Okuda T, Yagi H, Yamashita F, Hashida M.
    J Control Release; 2007 Apr 02; 118(2):262-70. PubMed ID: 17267065
    [Abstract] [Full Text] [Related]

  • 7. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
    Terada T, Iwai M, Kawakami S, Yamashita F, Hashida M.
    J Control Release; 2006 Apr 10; 111(3):333-42. PubMed ID: 16488046
    [Abstract] [Full Text] [Related]

  • 8. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice.
    Kawakami S, Wong J, Sato A, Hattori Y, Yamashita F, Hashida M.
    Biochim Biophys Acta; 2000 Dec 15; 1524(2-3):258-65. PubMed ID: 11113576
    [Abstract] [Full Text] [Related]

  • 9. In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier.
    Satoh T, Kakimoto S, Kano H, Nakatani M, Shinkai S, Nagasaki T.
    Carbohydr Res; 2007 Aug 13; 342(11):1427-33. PubMed ID: 17548066
    [Abstract] [Full Text] [Related]

  • 10. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs.
    Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M.
    J Pharm Sci; 2001 Feb 13; 90(2):105-13. PubMed ID: 11169527
    [Abstract] [Full Text] [Related]

  • 11. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.
    Zhang XQ, Wang XL, Zhang PC, Liu ZL, Zhuo RX, Mao HQ, Leong KW.
    J Control Release; 2005 Feb 16; 102(3):749-63. PubMed ID: 15681095
    [Abstract] [Full Text] [Related]

  • 12. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
    Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2000 Mar 16; 17(3):306-13. PubMed ID: 10801219
    [Abstract] [Full Text] [Related]

  • 13. Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines.
    Jain V, Nath B, Gupta GK, Shah PP, Siddiqui MA, Pant AB, Mishra PR.
    J Pharm Pharmacol; 2009 Mar 16; 61(3):303-10. PubMed ID: 19222902
    [Abstract] [Full Text] [Related]

  • 14. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting.
    Hattori Y, Kawakami S, Yamashita F, Hashida M.
    J Control Release; 2000 Dec 03; 69(3):369-77. PubMed ID: 11102677
    [Abstract] [Full Text] [Related]

  • 15. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.
    Fumoto S, Nakadori F, Kawakami S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2003 Sep 03; 20(9):1452-9. PubMed ID: 14567641
    [Abstract] [Full Text] [Related]

  • 16. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles.
    Huang G, Diakur J, Xu Z, Wiebe LI.
    Int J Pharm; 2008 Aug 06; 360(1-2):197-203. PubMed ID: 18539417
    [Abstract] [Full Text] [Related]

  • 17. Galactosylated poly(N-isopropylacrylamide) hydrogel submicrometer particles for specific cellular uptake within hepatocytes.
    Choi SH, Yoon JJ, Park TG.
    J Colloid Interface Sci; 2002 Jul 01; 251(1):57-63. PubMed ID: 16290701
    [Abstract] [Full Text] [Related]

  • 18. Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.
    Simmons CF, Schwartz AL.
    Mol Pharmacol; 1984 Nov 01; 26(3):509-19. PubMed ID: 6092900
    [Abstract] [Full Text] [Related]

  • 19. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages.
    Yeeprae W, Kawakami S, Yamashita F, Hashida M.
    J Control Release; 2006 Aug 28; 114(2):193-201. PubMed ID: 16876282
    [Abstract] [Full Text] [Related]

  • 20. Preparation of novel butyryl galactose ester-modified coix component microemulsions and evaluation on hepatoma-targeting in vitro and in vivo.
    Liu MJ, Qu D, Chen Y, Liu CY, Liu YP, Ding XF.
    Drug Deliv; 2016 Nov 28; 23(9):3444-3451. PubMed ID: 27198659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.